UNITED THERAPEUTICS Corp (UTHR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 1.5B 3B 4.5B Q3 '16: 1.6B Q4 '16: 1.6B Q1 '17: 1.6B Q2 '17: 1.6B Q3 '17: 1.7B Q4 '17: 1.7B Q1 '18: 1.7B Q2 '18: 1.7B Q3 '18: 1.7B Q4 '18: 1.6B Q1 '19: 1.6B Q2 '19: 1.5B Q3 '19: 1.5B Q4 '19: 1.4B Q1 '20: 1.4B Q2 '20: 1.4B Q3 '20: 1.4B Q4 '20: 1.5B Q1 '21: 1.5B Q2 '21: 1.6B Q3 '21: 1.7B Q4 '21: 1.7B Q1 '22: 1.8B Q2 '22: 1.8B Q3 '22: 1.9B Q4 '22: 1.9B Q1 '23: 2B Q2 '23: 2.1B Q3 '23: 2.2B Q4 '23: 2.3B Q1 '24: 2.5B Q2 '24: 2.6B Q3 '24: 2.8B Q4 '24: 2.9B Q1 '25: 3B Q2 '25: 3.1B Q3 '25: 3.1B Q4 '25: 3.2B Q1 '26: 3.2B Q2 '26: 3.2B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 1B 2B 3B Q4 '14: 1.2B Q1 '15: 1.2B Q2 '15: 1.3B Q3 '15: 1.3B Q4 '15: 1.4B Q1 '16: 1.5B Q2 '16: 1.5B Q3 '16: 1.5B Q4 '16: 1.5B Q1 '17: 1.5B Q2 '17: 1.5B Q3 '17: 1.6B Q4 '17: 1.6B Q1 '18: 1.6B Q2 '18: 1.6B Q3 '18: 1.5B Q4 '18: 1.4B Q1 '19: 1.4B Q2 '19: 1.4B Q3 '19: 1.4B Q4 '19: 1.3B Q4 '21: 1.6B Q1 '22: 1.6B Q2 '22: 1.7B Q3 '22: 1.7B Q4 '22: 1.8B Q1 '23: 1.8B Q2 '23: 1.9B Q3 '23: 2B Q4 '23: 2.1B Q1 '24: 2.2B Q2 '24: 2.3B Q3 '24: 2.5B Q4 '24: 2.6B Q1 '25: 2.7B Q2 '25: 2.7B Q3 '25: 2.8B Q4 '25: 2.8B Q1 '26: 2.7B Q2 '26: 2.7B Q4 '15 Q1 '17 Q2 '18 Q3 '19 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-600M 0 600M 1.2B 1.8B Q3 '16: 1B Q4 '16: 1.1B Q1 '17: 961.6M Q2 '17: 764.9M Q3 '17: 850.1M Q4 '17: 814.9M Q1 '18: 858.2M Q2 '18: 987.1M Q3 '18: 812.9M Q4 '18: 805.4M Q1 '19: -157.4M Q2 '19: -153.4M Q3 '19: -119.6M Q4 '19: -187.6M Q1 '20: 635M Q2 '20: 554.1M Q3 '20: 591.8M Q4 '20: 593.6M Q1 '21: 362.1M Q2 '21: 443.8M Q3 '21: 451.4M Q4 '21: 555.9M Q1 '22: 908.7M Q2 '22: 888.3M Q3 '22: 973.9M Q4 '22: 979.7M Q1 '23: 976.1M Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.2B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q4 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.4B Q3 '25: 1.5B Q4 '25: 1.5B Q1 '26: 1.4B Q2 '26: 1.4B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-500M 0 500M 1B 1.5B Q3 '16: 708M Q4 '16: 713.7M Q1 '17: 656.8M Q2 '17: 394.7M Q3 '17: 509.2M Q4 '17: 417.9M Q1 '18: 483.8M Q2 '18: 712.7M Q3 '18: 542.9M Q4 '18: 589.2M Q1 '19: -149.9M Q2 '19: -117.7M Q3 '19: -91.8M Q4 '19: -104.5M Q1 '20: 527.8M Q2 '20: 429.8M Q3 '20: 468.6M Q4 '20: 514.8M Q1 '21: 405.4M Q2 '21: 470.9M Q3 '21: 462.4M Q4 '21: 475.8M Q1 '22: 687.4M Q2 '22: 630.8M Q3 '22: 707.4M Q4 '22: 727.3M Q1 '23: 728.3M Q2 '23: 871.5M Q3 '23: 899.8M Q4 '23: 984.8M Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.2B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.3B Q4 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.3B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 150M 300M 450M Q4 '17: 105.7M Q1 '18: 144.6M Q2 '18: 187.4M Q3 '18: 219.8M Q4 '18: 198.7M Q1 '19: 174.6M Q2 '19: 139.6M Q3 '19: 120.7M Q4 '19: 117.6M Q1 '20: 111.9M Q2 '20: 111.1M Q3 '20: 102.1M Q4 '20: 108.1M Q1 '21: 107.7M Q2 '21: 119M Q3 '21: 122.7M Q4 '21: 122.5M Q1 '22: 125.4M Q2 '22: 117.9M Q3 '22: 127.4M Q4 '22: 151.6M Q1 '23: 178M Q2 '23: 212.4M Q3 '23: 245.3M Q4 '23: 257.5M Q1 '24: 278.1M Q2 '24: 291.8M Q3 '24: 304.8M Q4 '24: 309.7M Q1 '25: 329.3M Q2 '25: 339.1M Q3 '25: 356.9M Q4 '25: 384.4M Q1 '26: 425.3M Q2 '26: 437.2M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-600M 0 600M 1.2B 1.8B Q3 '15: 447.9M Q4 '15: 382.8M Q1 '16: 399.5M Q2 '16: 484.2M Q3 '16: 505.7M Q4 '16: 643.6M Q1 '17: 748.6M Q2 '17: 693.6M Q3 '17: 723.4M Q4 '18: 778.4M Q1 '19: -124.7M Q2 '19: -171.6M Q3 '19: -223.7M Q4 '19: -206.6M Q1 '20: 635.4M Q2 '20: 666.5M Q3 '20: 732M Q4 '20: 755.7M Q1 '21: 630.9M Q2 '21: 615.1M Q3 '21: 549.8M Q4 '21: 598.2M Q1 '22: 797.1M Q2 '22: 775.9M Q3 '22: 848.9M Q4 '22: 802.5M Q1 '23: 888.6M Q2 '23: 867.9M Q3 '23: 955.5M Q4 '23: 978M Q1 '24: 979.7M Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.3B Q1 '25: 1.4B Q2 '25: 1.4B Q3 '25: 1.6B Q4 '25: 1.6B Q1 '26: 1.6B Q2 '26: 1.7B Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-400M 0 400M 800M 1.2B Q3 '15: 427.4M Q4 '15: 333M Q1 '16: 349.9M Q2 '16: 428M Q3 '16: 450.9M Q4 '16: 605.6M Q1 '17: 698.8M Q2 '17: 633.3M Q3 '17: 650.2M Q4 '18: 594M Q1 '19: -296.6M Q2 '19: -310.3M Q3 '19: -334.5M Q4 '19: -290.3M Q1 '20: 563.8M Q2 '20: 597M Q3 '20: 660.3M Q4 '20: 696.4M Q1 '21: 574M Q2 '21: 560.1M Q3 '21: 487.3M Q4 '21: 477.4M Q1 '22: 673.4M Q2 '22: 651.5M Q3 '22: 679M Q4 '22: 663.7M Q1 '23: 722M Q2 '23: 673.6M Q3 '23: 764.3M Q4 '23: 747.6M Q1 '24: 752.4M Q2 '24: 877.9M Q3 '24: 898.1M Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1B Q1 '26: 1B Q2 '26: 1.1B Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '13: 52.6M Q3 '13: 53.7M Q1 '14: 56.7M Q2 '14: 53.3M Q3 '14: 47.3M Q1 '15: 46.7M Q2 '15: 51.9M Q3 '15: 50.2M Q1 '16: 48.7M Q2 '16: 46.9M Q3 '16: 46.2M Q1 '17: 45.9M Q2 '17: 44.9M Q3 '17: 44.1M Q1 '18: 43.9M Q2 '18: 43.4M Q3 '18: 44M Q1 '19: 43.7M Q2 '19: 44M Q3 '19: 44M Q1 '20: 44.1M Q2 '20: 44.4M Q3 '20: 44.6M Q1 '21: 46.4M Q2 '21: 47.3M Q3 '21: 47.6M Q1 '22: 47.7M Q2 '22: 48.1M Q3 '22: 48.7M Q1 '23: 49.6M Q2 '23: 49.5M Q3 '23: 49.7M Q1 '24: 49.7M Q2 '24: 47.5M Q3 '24: 48.4M Q1 '25: 48.6M Q2 '25: 48.3M Q3 '25: 47.3M Q1 '26: 47.2M Q2 '26: 45.8M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.00 0.00 10.00 20.00 30.00 Q3 '16: 14.83 Q4 '16: 15.16 Q1 '17: 14.21 Q2 '17: 8.57 Q3 '17: 11.34 Q4 '17: 9.34 Q1 '18: 11.02 Q2 '18: 16.25 Q3 '18: 12.40 Q4 '18: 13.45 Q1 '19: -3.44 Q2 '19: -2.76 Q3 '19: -2.17 Q4 '19: -2.45 Q1 '20: 11.99 Q2 '20: 9.74 Q3 '20: 10.57 Q4 '20: 11.54 Q1 '21: 9.03 Q2 '21: 10.27 Q3 '21: 9.85 Q4 '21: 10.02 Q1 '22: 14.44 Q2 '22: 13.20 Q3 '22: 14.69 Q4 '22: 15.00 Q1 '23: 14.83 Q2 '23: 17.66 Q3 '23: 18.13 Q4 '23: 19.81 Q1 '24: 21.12 Q2 '24: 21.73 Q3 '24: 22.74 Q4 '24: 24.62 Q1 '25: 25.08 Q2 '25: 25.64 Q3 '25: 26.41 Q4 '25: 27.89 Q1 '26: 27.08 Q2 '26: 27.94 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.